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to test the hypothesis that subjects with TAO have a greater degree of tobacco depen- 
dence than do control subjects with coronary atherosclerosis (CAD). 
Methods: Subjects with TAO (n = 218, confirmed by angiography, biopsy, or noninvasive 
arterial testing) or CAD (n=343, diagnosed by coronary angiography) were mailed a stan- 
dardized questionnaire regarding tobacco use, to which 103 and 273 responded, raspec- 
tively. Degree of tobacco dependence in each group was ascertained by several 
methods, including the Fagerstrtim Test for Nicotine Dependence Questionnaire. 
Resuks: The TAO group was younger at Index date (year of first diagnosis for TAO 
patients, year of PTCA for CAD patients) (TAO 37.6e9.0 vs CAD 43.3+4.9 yrs, P<.OOOl), 
but the groups did not differ in age at first tobacco exposure (TAO 16.7k3.1 vs CAD 
17.3k4.2 yrs, p=.67), current tobacco use at time of survey (TAO 54% vs CAD 46%, 
p=.17). or Fagerstrbm score (TAO 4.7t2.3 vs CAD 5.1~2.3, p=.24). Kaplan Meier curves 
showed no significant difference in time lo stopping tobacco use after first diagnosis 
(p=.798). TAO subjects smoked fewer cigarettes per day than CAD subjects (TAO 
22.3*10.7 vs CAD 27.7k15.3 cigarettes/day, p=.OO3). However, among current smokers 
(n=l53). the groups did not seem lo differ in number of cigarettes/day (19.6+7.9 vs. 
22.5+11 .l, p=.20). Individuals in the TAO group appeared to be more likely to have made 
a serious attempt to quit smoking than those in the CAD group (TAO 97%% vs CAD 
90%, p=O.O5). 
Conclusions: In contrast to case reports of extreme tobacco dependence in the TAO pop- 
ulation, the degree of tobacco dependence in subjects with TAO is similar to matched 
subjects with CAD. 
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1200-l 34 Low Bone Mineral Density Predicts Significant 
Coronary Artery Disease at Cardiac Catheterization 
Hillarv H. Traq Christine Z. Dickmson, Judith A. Boura, William W. ONeill, Pamela A. 
Marcovitz, William Beaumont Hospital, Royal Oak, MI 
Background: Osteoporosis and coronary disease (CAD) share several risk factors (age, 
diabetes, hyperlenslon [HTN], and smoking) and may be related. The purpose of this 
study is lo investigate whether osteoporosis is predictive of significant CAD compared 
with traditional risk factors. 
Methods: Dual energy x-rays absorp~iometry (DEXA) scan and cardiac cathererization 
were performed on 209 patients (163 females, 26 males) between l/2000 and 712002. 
DEXA scans were classified into 3 groups: normal, osteopenia, and osteoporosis based 
on World Health Organization criteria. Angiograms were classified as having significant 
CAD if 2 50% luminal stenosis was noted in a major coronary artery. Clinical variables 
(age, HTN, diabetes, smoking, family history of CAD, hyperlipidemia) were examined. 
Results: 117 patients had significant CAD. Patients with and without CAD were similar 
clinically and demographically. Unlvariate predictors of CAD ware osteoporosis, diabe- 
tes, hypertension, and family history of premature CAD (table). On multivariate analysts, 
odds ratio (OR) for CAD was highest for osteoporosis: O&5.0 (95% confidence interval, 
2.25-l 1 .l [PC O.OOOl]). 
Conclusion: The presence of osteoporosis predicts significant coronary stenosis with 
higher odds ratio than traditional risk factors. Our study is the flrsst to report an increase in 
documented CAD in patlents with osteoporosis. 
Variable Odds ratio 95% confidence interval P- value 
Osteoporosis 5 2.25 - 11.1 co.ooo1 
Hypertension 2.37 1.04 - 5.4 0.041 
Family history of premature CAD 2.79 1.26-6.18 0.012 
Diabetes mellitus 3.3 1.6 6.79 0.0012 
1200-135 Rheumatoid Arthritis Is Not Associated With Myocardial 
Infarction After Controlling for Other Risk Factors 
Jefferson T. Baer, Jesse A. Berlin, Daniel A. Albert, Stephen E. Kimmel, Universtty of 
Pennsylvania, Philadelphia, PA 
Background: Previous studies have suggested that patients with rheumatoid arthritis 
(RA) have an increased rate of cardiovascular death and myocardial infarction (Ml) com- 
pared to Ihe general population. However, the majority of these studies failed to control 
for known cardiac nsk factors, some of which appear to be more common in patients with 
RA. 
Methods: A case-control study of first MI. ages 40 through 75, was conducted among 36 
hospitals in a B-county area during a 3.year period. Cases were patients hospitalized 
with a first nonfatal MI, and controls ware randomly selected from the same geographic 
area. Self-report of physician diagnosed RA was collected via telephone Interviews, 
along with detailed information regardmg cardiac risk factors and current medications 
using state-of-the-art methods. Multivariable logistic regression was used to adjust for 
age, sex, race, hormone replacement therapy, body mass index (BMI), cigarette smok- 
ing, insurance, exercise, income, education, history of coronary disease, family history, 
hypertension (HTN), diabetes mellitus (DM), hyperlipidemia, nonsteroidal anti-inflamma- 
tory drug use, aspirin use, disease-modifying anti-rheumatic drug use, and number of 
doctor visits. 
Results: 1078 cases (4.74% with RA) and 4255 controls (3.62% with RA) were inter- 
wewed. There was an increased risk of myocardial mfarction (MI) in patients with RA in 
the unadjusted model (OR 1.42, 95% Cl: 1.02-l .97). However, after adjusting for con- 
founding, there was no increased risk from RA (OR 0.86, 95% Cl: 0.58-1.29). The vari- 
ables responsible for confounding were age, HTN, DM, BMI, history of coronary disease. 
education and number of doctor visits. There were no subgroups at mcreased risk of Ml 
from RA. 
Conclusions: Previous studies showing an increased risk of cardiovascular death III 
patients with RA did not control for known cardiac risk factors. The current study showed 
an increased risk of MI in patients with RA that was solely explained by RA patients’ 
greater prevalence of several rksk factors. Physicians should aggressively screen for and 
modify common cardiac risk factors in patients with RA. 
1200-l 36 Green Tea Derived Polyphenol Antioxidant, EGCG, 
Differentially Modulates Developing Compared to 
Mature Atherosclerotic Lesions in Apo E -/- Mice 
Stephanie M. Babbidqg, Xiaonmg Zhao. Ramprasad Dandillaya, Juliana Yano, Paul C. 
Dimayuga, Bojan Cercek, Prediman K. Shah, Kuang-Yuh Chyu, Cedars-Sinai Medical 
Center, Los Angeles, CA 
Background: Atherosclerosis starts at a young age, but therapy IS generally begun 
when the disease is well established. Therapy such as green tea derived polyphenol anti- 
oxidant epigallocatechm gallate (EGCG) may be more effective when applied during the 
developing rather than established phase of atherosclerosis. 
Hypothesis: Developing atherosclerotic lesions are differentially modulated by anti-oxi- 
dant therapy compared lo mature atherosclerotic lesions. 
Methods: Newly developing atherosclerotic lesions were Induced by placing a carotid 
cuff in apoE (-i-) hypercholesterolemic mice at 26 weeks of age. EGCG (10 mgikg, n=7) 
or PBS (n=7) was injected i.p. daily. Sections of cuffed arteries ware stained for PCNA. 
H&E and oil-red-O. Aortic sinus plaques from the same animals were stained for collagen 
content and macrophage. Plasma cholesterol and antioxidant potential were also mea- 
sured. 
Results: Newly developed lipid-rich atheroma in the carotid artery were smaller in the 
EGCG group compared to the PBS group 21 days after cuffing. EGCG treatment 
reduced medial PCNA expression 3 days after cuffing (Table). Mature aortic sinus 
plaques were not affected by EGCG (Table). BW and cholesterol levels were compara- 
ble in both groups. EGCG level 1 hour after injection was 138 * 44 ng/mL (n=5). 
Conclusion: Our data suggest that antioxidant therapy inhibits the formation of develop- 
ing, but not mature plaques. This observation implies timing of ant&dam therapy may 
be critical for antlatherogenic effect. 
Gr Carotid Carotid Sinus Sinus Plaque Sinus Plasma 
o” PCNA plaque Size Plaque Macrophage Plaque antioxidant 
P (day 3) (mm2, Size (mn?) (%) Collagen level# 
(%) 
E 7.4i6.2* 0.014iO.008 0.899&0.16 14.6k2.8 4O.lk6.6 1.147 * 
G (37 * 0.579* 
C sections) 
G 
P 11.9i10.7 0.031~0.013 0.851*0.16 17.2+4.6 
B (25 
S sections) 
42.5k3.2 0.262 f 
0.290 
meankstd; *p < 0.05 vs. PBS group; #mM uric acid equivalents 
1200-137 Downregulation of Microfilament Expression in 
Atherosclerotic Plaque Is Mediated bv Oxidized Low- 
Density Lipoprotein’ 
Koichi Ono Tao Peng, Jie Du, Yusuke Higashi. Yoshifumi Okura, Hiroyuki Itabe, Arkady -I 
Goubine. PatrIce Delafontaine, The University of Kansas Medical Center, Kansas City, 
KS 
The cellular microfilament system is a highly dynamic network comprised of multiple pro- 
teins that are essential for cell motility, contraction, cell-cell and cell-substrate interac- 
tions, signalmg pathways, gene expression and cell differentiation. To examine the 
regulation of Vascular Smooth Muscle Cell (VSMC) mvxofilaments in atherosclerotic 
plaque development we performed immunostaining fora-, p-actin and wmentm in human 
femoral and carotid atherosclerotic plaques (n=20). There was a marked reduction in a- 
actin and vimentin expression in VSMC in advanced plaque. To identify stimuli that 
downregulate microfilament components in plaque, we incubated human VSMC with O- 
100 uglml Oxidized LDL (OxLDL), an important proatherogenic molecule, or o-100 us/ml 
native LDL (nLDL) and measured cytoskeletal protein expression by western immunob- 
lotting. OxLDL, but not nLDL, dose dependently reduceda-actin and vimentin expression 
(21 r 5%, n=8. pc.05, and 52 * 6%. n=19. pcO.0001, respectively, with 100 ug/ml 
OxLDL) and non-significantly increased p-&in expresston. To determine intracellular 
signaling pathways mediating OxLDL effects on microfilaments we studied the effect of 
candidate proteins implicated in OxLDL stgnalmg. OxLDL components are high-affinity 
liaands for the PPARvnuclear recer&r. but the effect of OxLDL was not blocked bv the 
P>ARy inhibitor, PGF; a, 200 nM, and the synthetic PPARy lkgand ciglitazone (0.1O’uM) 
did not reaulate vimentm or a-actin exmesslon. Furthermore. inhibition of the ~38 MAPK 
pathway (88203580, 10 uM) did not modify OxLDL effects, Indicating that the ability of 
OxLDL to regulate vlmentinla-actln was not mediated via a p38 MAPK dependent path- 
way. In conclusion: 
